June 2026

• OpenAI has released a major memory upgrade for ChatGPT, while Apple has integrated an AI agent into iMessage for the first time. • DoorDash reported a significant increase in engagement, with its new advertising format doubling user click rates. • Meta and Google are attempting to attract users from OpenClaw, a free tool by an Austrian developer that rapidly grew to three million users.

• Bobby Deol's new film, *Bandar*, experienced a slow start at the box office on its opening day, June 5, 2026. • The movie is currently trailing behind the performance of another release, *Hai Jawani Toh Ishq Hona Hai*. • These early figures are critical as they determine the film's commercial viability and potential for longevity in a competitive market.

• On June 5, 2026, Thailand’s SET Index closed at 1,582.60 points, marking a decrease of 12.19 points or 0.76% with a total trading value of THB 67.94 billion. • Market analysts attribute this decline to consolidation and profit-taking by investors after the index failed to maintain its position above the key resistance level of 1,600 points. • In separate research, Deloitte found that Thai Gen Z and Millennial populations are increasingly prioritizing financial stability in response to ongoing economic pressures.

• On June 5, 2026, digital forensics investigators tracked unauthorized access to a Gaza aid registration platform and analyzed a Magento cache flaw exploitation. • Security researchers identified an npm supply-chain compromise affecting 36 packages and exposed manipulation techniques involving Gemini notifications. • Law enforcement authorities successfully disrupted scam infrastructure linked to fraudulent compounds located in Southeast Asia.

• A landmark week in oncology saw pivotal data released for lung, prostate, bladder, and haematological cancers, alongside major capital investments in AI drug discovery, RNA therapeutics, and gene editing. • New data for embolisation-eligible hepatocellular carcinoma (HCC) showed a 30% incremental improvement over TACE, though overall survival (OS) data remains immature. • The proposed combination of tremelimumab, durvalumab, and lenvatinib plus TACE raises concerns regarding cost, complexity, and patient tolerability compared to the current standard of care.

• An experimental drug called daraxonrasib demonstrated a significant survival benefit for patients with metastatic pancreatic cancer in a global Phase 3 clinical trial. • The study involving 500 patients showed that those receiving daraxonrasib had a median overall survival of 13.2 months, nearly double the 6.7 months seen in the standard chemotherapy group. • This breakthrough is critical as it reduced the risk of death by 60% for patients whose disease had already progressed after initial chemotherapy.

• The Dow Jones Industrial Average soared 875 points to reach a new record close on Thursday, June 4, 2026. • Gains were primarily driven by strong performances from UnitedHealth Group and Goldman Sachs, which helped the index overcome a tech-led pullback. • In contrast, the S&P 500 faced headwinds as Broadcom and other AI chipmaker stocks experienced significant declines, and oil prices retreated.